Streetbeat News

Regulatory

CRBU

PFE

Pfizer Inc. has increased its stake in Caribou Biosciences, Inc. to 7.1%, according to a 13G filing with the SEC.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:46 pm

SPY

VGK

The European Union has sealed a new transatlantic data transfers pact with the United States, according to Reuters. This agreement is expected to ensure that companies can continue to transfer personal data across the Atlantic, a process that is crucial for many businesses.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:44 pm

JD

NVO

QQQ

SPY

TSLA

The U.S. consumer price index (CPI) inflation report for June is set to be released on Wednesday. Economists anticipate the annual U.S. headline inflation rate to drop from 4% to 3.1%, marking the 12th consecutive month of declines. The core CPI is expected to decline from 5.3% to 5%. The market remains uncertain about the possibility of two rate hikes this year. Previous CPI readings have impacted various stocks and ETFs.

Portfolio Pulse from Piero Cingari

July 10, 2023 | 1:36 pm

IBRX

ImmunityBio, Inc. (NASDAQ:IBRX) announced findings from a Phase 1 study indicating that allogeneic cytokine-induced memory-like (CIML) natural killer (NK) cells used in combination with ImmunityBio's IL-15 superagonist N-803 may induce tumor regression in advanced head-and-neck cancer patients. The study, sponsored by Dana-Farber Cancer Institute, showed that tumor regression was associated with expansion of the NK cell type with cytolytic activity. The results may have potential implications for many of the estimated 68,000 men and women in the United States who are diagnosed with head-and-neck cancers annually.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:31 pm

EPOW

Sunrise New Energy Co., Ltd. (NASDAQ:EPOW) has been granted ISO9001:2015 and IATF16949:2016 certifications for its quality management system in the design and manufacturing of anode material for lithium-ion batteries. The certifications are recognized by the China National Accreditation Service for Conformity Assessment (CNAS).

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:27 pm

GSK

PFE

The U.K. Medicines and Healthcare Products Regulatory Agency has approved GSK Plc's Arexvy, a vaccine for respiratory syncytial virus (RSV), for adults aged 60 and older. The approval is supported by data from a phase 3 vaccine efficacy trial. In June, the U.S. CDC's Advisory Committee recommended the use of RSV vaccines from Pfizer Inc and GSK for older adults. GSK shares are down 0.03% at $33.80 during the premarket session on the last check Monday.

Portfolio Pulse from Vandana Singh

July 10, 2023 | 1:26 pm

ATOS

Atossa Therapeutics, Inc. (NASDAQ:ATOS) has enrolled 170 patients in its ongoing Phase 2 Karisma-Endoxifen clinical trial, with full enrollment expected by Q4 2023. The trial is studying the efficacy of oral (Z)-endoxifen in premenopausal women with measurable breast density. The company's President and CEO, Dr. Steven Quay, expressed optimism about the potential of (Z)-endoxifen to reduce breast density and decrease the risk of breast cancer.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:16 pm

GOVX

GeoVax Labs, Inc. (NASDAQ:GOVX) presented Phase 1/2 clinical trial data for its gene therapy candidate, Gedeptin, at the AACR-AHNS Head and Neck Cancer Conference. The ongoing trial is evaluating the safety and efficacy of Gedeptin therapy in patients with recurrent head and neck squamous cell carcinoma. The study, funded in part by the FDA, has shown no serious adverse events and evidence of a reduction in tumor size. GeoVax anticipates completion of the trial by the end of 2023.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:03 pm

SISI

Shineco, Inc. (NASDAQ:SISI) announced that its subsidiary, Changzhou Biowin Pharmaceutical Co., Ltd., received marketing and distribution approval from China's National Medical Products Administration (NMPA) for its Cardiac 5-Minute Test. The test, which can detect three major cardiac markers in one test, is the first and only product on the market in China to complete the detection process for cardiac markers within 5 minutes. The approval is expected to support Biowin's business development efforts in the Point-of-Care Testing industry.

Portfolio Pulse from Happy Mohamed

July 10, 2023 | 1:02 pm

SIVBQ

SVB Financial Group has filed a lawsuit against the U.S. Federal Deposit Insurance Corporation (FDIC) to recover $1.93 billion that was seized during the takeover of Silicon Valley Bank in March. The FDIC claims that SVB Financial's failure reduced its insurance fund by $16 billion and it can legally hold the seized funds. The bank is facing reorganization-related issues due to a lack of funds.

Portfolio Pulse from Lekha Gupta

July 10, 2023 | 12:55 pm